Phoenestra GmbH

Phoenestra develops an end-to-end approach for a broad range of stem cell-derived products: Xeno-free induced pluripotent stem cell lines IPSC) Telomerized MSC (TERT) lines (GMP-grade, licensed from Evercyte) Bulk iPS cells and TERT/MSCs from controlled bioreactor cultivations Extracellular Vesicle preparations from various cell lines / types Engineered “universal” stem cell lines (in development) iPS cell-derived (pre-)differentiated cells (in development) Processed cells (in development) Phoenestra is establishing GMP laboratories for GMP cell banking and manufacturing of (pre-)clinical study material Based on these platform technologies, we are developing stem cell-derived therapeutic modalities (we are looking for partners) and offer R&D as well as GMP services. Especially for vesicle-based products we are offering a One-stop-shop concept together wit our partner companies Evercyte (MSC/TERT lines, relevant bioassays) and TAmiRNA (RNA analytics, -omics, bioinformatics, biomarker developmet) Privacy Policy and Imprint can be accessed by clicking "Contact us"